Trade War Expansion? STAR Board Aims To Keep Lucrative China Biotech IPOs At Home

 
• By Brian Yang
  
Money Wave
CHIPSCREEN AMONG FIRST BIOPHARMAS TO GO PUBLIC ON SHANGHAI'S NEW STAR BOARD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia